Overview
The opportunity exists for Wholesale Investors to express interest in Ora Pharm Limited (Ora Pharm) The Company Ora Pharm is ideally positioned to become the leading New Zealand supplier of high value, pharmaceutical grade medicinal cannabis products to meet rapidly growing international and domestic demand. Ora Pharm is secured a location in North Waikato that is ideally suited to growing cannabis, both indoors (year-round) and outdoors (seasonally). Using specialized greenhouses developed in the US but little-known in the Southern Hemisphere, Ora Pharm is preparing to own the most efficient and productive growing facilities for cannabis in New Zealand. In a market with very high regulatory barriers to entry and competitors beginning to operate, Ora Pharm stands out as the only company with significant market experience and a strong US market platform to drive growth. Zoe Reece (CEO and Founder) and Stuart Wilcox (Executive Chairman and Head of International Business Development) bring a wealth of experience having previously held senior executive positions at Curaleaf, one of the largest and most respected cannabis corporation in North America with a market capitalisation of over US$11.5 billion. December 2022 Updates The Offer Ora Pharm is seeking to raise up to NZ$7.5 million in equity capital through a Series A Funding Round from wholesale and institutional investors. The capital raised will support the expansion of cultivation capacity, develop processing and manufacturing capability and the freehold purchase of land. For more information please refer to the Information Memorandum in the documents section. To access further information and be put in contact with the arranger, Register Interest. Curious about medicinal cannabis? Have you heard about opportunities in medicinal cannabis, but feel hesitant about this emerging industry? Perhaps you’ve invested in early-stage cannabis businesses, but you’d like to understand the sector better? Ora Pharm’s global directors are hosting a series of seminars throughout New Zealand in February and March, bringing you insights and education on the fledgling medicinal cannabis sector. Suitable for investors, medical professionals, public sector officials and media, you’ll learn about: Ora Pharm’s leadership team are New Zealand’s most experienced medicinal cannabis professionals, with global experts invested in and leading the company's development in Aotearoa. Ora Pharm is the New Zealand medicinal cannabis venture with superior knowledge of global markets, production systems, and go-to-market strategy for finished medical cannabis products internationally. Ora Pharm are listed on Syndex, with key members of the Board and leadership team available to answer your questions around investment following each seminar. THE SPEAKERS STUART WILCOX | Executive Chairman, Ora Pharm ZOE REECE | CEO, Ora Pharm BLAKE SMITH | Chief Science Officer, Ora Pharm & CEO Zion Pharmaceutical SESSION TIMES Ora Pharm will be hosting seminars in the following locations. AUCKLAND - Tuesday February 28th WELLINGTON - Wednesday, March 1st CHRISTCHURCH - Thursday, March 2nd QUEENSTOWN - Friday, March 3rd For further information please refer to the invitation in the documents tab and to reserve your seat, please email [email protected] To request a private meeting with Ora Pharm’s directors, please email [email protected] or phone Zoe Reece (CEO) on 022 532 5696. For more information on Ora Pharm, visit their website here: https://orapharm.co.nz/
Investment Details
Investment Type: Wholesale
Wholesale Investment Type: NZ Wholesale Equities
Transaction Size:NZD 7,500,000.00
Pre-money valuation:NZD 25,401,532.00
Minimum Capital Raise:NZD 2,100,000.00
Unit Price:NZD 3.55
Minimum Investment Size:NZD 50,000.00
Advisor
Document Name | Description | Date Uploaded |
---|
You do not have any investments to report on.
No trade history available for this issue.